- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/08 - 1,2,5-OxadiazolesHydrogenated 1,2,5-oxadiazoles
Patent holdings for IPC class C07D 271/08
Total number of patents in this class: 197
10-year publication summary
|
16
|
19
|
37
|
23
|
6
|
14
|
2
|
7
|
5
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Incyte Holdings Corporation | 660 |
23 |
| Bayer Cropscience AG | 2035 |
19 |
| Incyte Corporation | 1024 |
11 |
| BASF SE | 20933 |
10 |
| Incyte Holdings Corporation and Incyte Corporation | 82 |
7 |
| Bayer Intellectual Property GmbH | 2499 |
6 |
| Bayer AG | 3330 |
5 |
| Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 172 |
5 |
| Dice Alpha, Inc. | 18 |
5 |
| Nicox S.A. | 138 |
4 |
| Nanjing Huawe Medicine Technology Group Co., Ltd. | 9 |
4 |
| Merck Sharp & Dohme LLC | 3748 |
4 |
| Hinova Pharmaceuticals Inc. | 97 |
3 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 304 |
3 |
| Shandong Luye Pharmaceutical Co., Ltd. | 63 |
3 |
| Shanghai Hansoh Biomedical Co., Ltd. | 264 |
3 |
| Merck Sharp & Dohme Corp. | 2194 |
2 |
| Galderma Research & Development | 405 |
2 |
| Hangzhou Normal University | 61 |
2 |
| Hydra Biosciences, Inc. | 40 |
2 |
| Other owners | 74 |